Pseudomonas aeruginosa DSM 21384 is a human pathogen of the family Pseudomonadaceae.
human pathogen Bacteria
SI-ID 204652
| @ref 20215 |
Last LPSN update
2026-02-09 11:24:05 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Pseudomonadaceae |
| Genus Pseudomonas |
| Species Pseudomonas aeruginosa |
| Full scientific name Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 15660 | CASO AGAR (MERCK 105458) (DSMZ Medium 220) | Medium recipe at MediaDive  | Name: CASO AGAR (MERCK 105458) (DSMZ Medium 220) Composition: Agar 15.0 g/l Casein peptone 15.0 g/l NaCl 5.0 g/l Soy peptone 5.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 15660 | positive | growth | 37 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68369 | 29016 ChEBI | arginine | + | hydrolysis | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | - | fermentation | from API 20NE |
| 68369 | 16899 ChEBI | D-mannitol | + | assimilation | from API 20NE |
| 68369 | 16024 ChEBI | D-mannose | - | assimilation | from API 20NE |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 4853 ChEBI | esculin | - | hydrolysis | from API 20NE |
| 68369 | 5291 ChEBI | gelatin | + | hydrolysis | from API 20NE |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 68369 | 30849 ChEBI | L-arabinose | - | assimilation | from API 20NE |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68369 | 59640 ChEBI | N-acetylglucosamine | + | assimilation | from API 20NE |
| 68369 | 17632 ChEBI | nitrate | + | reduction | from API 20NE |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| 68369 | 16199 ChEBI | urea | + | hydrolysis | from API 20NE |
Phages| @ref | Name | Strain number | |
|---|---|---|---|
| 124042 | Pseudomonas phage D3 | DSM 21384 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Relation between vitamin D deficiency and Pseudomonas aeruginosa colonization in patients with bronchiectasis. | Wen YH, Dai RX, Yang H, Lin JL, Tao RJ, Yang L, Xu JF, Lu HW. | BMC Pulm Med | 10.1186/s12890-025-03548-6 | 2025 | | |
| Insights on Pseudomonas aeruginosa Carbohydrate Binding from Profiles of Cystic Fibrosis Isolates Using Multivalent Fluorescent Glycopolymers Bearing Pendant Monosaccharides. | Chance DL, Wang W, Waters JK, Mawhinney TP. | Microorganisms | 10.3390/microorganisms12040801 | 2024 | | |
| OLFML3 Promotes IRG1 Mitochondrial Localization and Modulates Mitochondrial Function in Macrophages. | Yu Q, Mei H, Gu Q, Zeng R, Li Y, Zhang J, Gao C, Fang H, Qu J, Liu J. | Int J Biol Sci | 10.7150/ijbs.103859 | 2025 | | |
| Sinonasal Stent Coated with Slow-Release Varnish of Chlorhexidine Has Sustained Protection against Bacterial Biofilm Growth in the Sinonasal Cavity: An In Vitro Study. | Cataldo Russomando A, Vogt Sionov R, Friedman M, Gati I, Eliashar R, Steinberg D, Gross M. | Pharmaceutics | 10.3390/pharmaceutics13111783 | 2021 | | |
| Pseudomonas aeruginosa Induces Interferon-beta Production to Promote Intracellular Survival. | Yang L, Zhang YW, Liu Y, Xie YZ, Weng D, Ge BX, Liu HP, Xu JF. | Microbiol Spectr | 10.1128/spectrum.01550-22 | 2022 | | |
| Airway acidification impaired host defense against Pseudomonas aeruginosa infection by promoting type 1 interferon beta response. | Liu Y, Xie YZ, Shi YH, Yang L, Chen XY, Wang LW, Qu JM, Weng D, Wang XJ, Liu HP, Ge BX, Xu JF. | Emerg Microbes Infect | 10.1080/22221751.2022.2110524 | 2022 | | |
| Cilia Stimulatory and Antibacterial Activities of T2R Bitter Taste Receptor Agonist Diphenhydramine: Insights into Repurposing Bitter Drugs for Nasal Infections. | Kuek LE, McMahon DB, Ma RZ, Miller ZA, Jolivert JF, Adappa ND, Palmer JN, Lee RJ. | Pharmaceuticals (Basel) | 10.3390/ph15040452 | 2022 | | |
| Adipose-Derived Mesenchymal Stem Cells Ameliorating Pseudomonas aeruginosa-induced Acute Lung Infection via Inhibition of NLRC4 Inflammasome. | Li LL, Zhu YG, Jia XM, Liu D, Qu JM. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.581535 | 2020 | | |
| A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics. | Verderosa AD, Dhouib R, Hong Y, Anderson TK, Heras B, Totsika M. | Sci Rep | 10.1038/s41598-021-81007-y | 2021 | | |
| Reversal of Polymicrobial Biofilm Tolerance to Ciprofloxacin by Blue Light plus Carvacrol. | Li Y, Wu MX. | Microorganisms | 10.3390/microorganisms9102074 | 2021 | | |
| Metabolism | Plant flavones enhance antimicrobial activity of respiratory epithelial cell secretions against Pseudomonas aeruginosa. | Hariri BM, McMahon DB, Chen B, Adappa ND, Palmer JN, Kennedy DW, Lee RJ. | PLoS One | 10.1371/journal.pone.0185203 | 2017 | |
| Metabolism | PAR-2-activated secretion by airway gland serous cells: role for CFTR and inhibition by Pseudomonas aeruginosa. | McMahon DB, Carey RM, Kohanski MA, Adappa ND, Palmer JN, Lee RJ. | Am J Physiol Lung Cell Mol Physiol | 10.1152/ajplung.00411.2020 | 2021 | |
| Design of a spaceflight biofilm experiment. | Zea L, Nisar Z, Rubin P, Cortesao M, Luo J, McBride SA, Moeller R, Klaus D, Muller D, Varanasi KK, Muecklich F, Stodieck L. | Acta Astronaut | 10.1016/j.actaastro.2018.04.039 | 2018 | | |
| Metabolism | Genetically engineered distal airway stem cell transplantation protects mice from pulmonary infection. | Zhou YQ, Shi Y, Yang L, Sun YF, Han YF, Zhao ZX, Wang YJ, Liu Y, Ma Y, Zhang T, Ren T, Dale TP, Forsyth NR, Jin FG, Qu JM, Zuo W, Xu JF. | EMBO Mol Med | 10.15252/emmm.201810233 | 2020 | |
| Pathogenicity | Machine Learning Platform to Discover Novel Growth Inhibitors of Neisseria gonorrhoeae. | Pereira JC, Daher SS, Zorn KM, Sherwood M, Russo R, Perryman AL, Wang X, Freundlich MJ, Ekins S, Freundlich JS. | Pharm Res | 10.1007/s11095-020-02876-y | 2020 | |
| Enzymology | Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. | Abdulnour RE, Sham HP, Douda DN, Colas RA, Dalli J, Bai Y, Ai X, Serhan CN, Levy BD. | Mucosal Immunol | 10.1038/mi.2015.129 | 2016 | |
| Molecular viability testing of bacterial pathogens from a complex human sample matrix. | Weigel KM, Jones KL, Do JS, Melton Witt J, Chung JH, Valcke C, Cangelosi GA. | PLoS One | 10.1371/journal.pone.0054886 | 2013 | | |
| Metabolism | Neutrophil extracellular trap formation requires OPA1-dependent glycolytic ATP production. | Amini P, Stojkov D, Felser A, Jackson CB, Courage C, Schaller A, Gelman L, Soriano ME, Nuoffer JM, Scorrano L, Benarafa C, Yousefi S, Simon HU. | Nat Commun | 10.1038/s41467-018-05387-y | 2018 | |
| GIMAP6 regulates autophagy, immune competence, and inflammation in mice and humans. | Yao Y, Du Jiang P, Chao BN, Cagdas D, Kubo S, Balasubramaniyam A, Zhang Y, Shadur B, NaserEddin A, Folio LR, Schwarz B, Bohrnsen E, Zheng L, Lynberg M, Gottlieb S, Leney-Greene MA, Park AY, Tezcan I, Akdogan A, Gocmen R, Onder S, Rosenberg A, Soilleux EJ, Johnson E, Jackson PK, Demeter J, Chauvin SD, Paul F, Selbach M, Bulut H, Clatworthy MR, Tuong ZK, Zhang H, Stewart BJ, Bosio CM, Stepensky P, Clare S, Ganesan S, Pascall JC, Daumke O, Butcher GW, McMichael AJ, Simon AK, Lenardo MJ. | J Exp Med | 10.1084/jem.20201405 | 2022 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive24866.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License